Skip to main content
. 2018 Mar 27;8(3):e020851. doi: 10.1136/bmjopen-2017-020851

Table 3.

OR of body silhouettes trajectories for excessive daytime sleepiness

Model 1
OR (95% CI)
Model 2
OR (95% CI)
Model 3
OR (95% CI)
Model 4
OR (95% CI)
Trajectory
 Lean stable 1 (ref) 1 (ref) 1 (ref) 1 (ref)
 Lean increase 1.12 (0.89 to 1.41) 1.09 (0.86 to 1.36) 1.06 (0.84 to 1.34) 1.06 (0.81 to 1.37)
 Lean-marked increase 1.46 (1.21 to 1.76) 1.41 (1.16 to 1.69) 1.39 (1.15 to 1.68) 1.46 (1.18 to 1.81)
 Moderate stable 1.02 (0.87 to 1.21) 1.02 (0.87 to 1.21) 1.03 (0.87 to 1.21) 1.00 (0.83 to 1.21)
 Heavy stable 1.30 (1.02 to 1.64) 1.26 (0.99 to 1.59) 1.25 (0.98 to 1.60) 1.24 (0.94 to 1.62)
Age (per 1-year increase) 0.96 (0.95 to 0.97) 0.96 (0.95 to 0.97) 0.96 (0.95 to 0.97) 0.96 (0.95 to 0.98)
Male sex 0.97 (0.85 to 1.11) 1.04 (0.91 to 1.19) 1.06 (0.92 to 1.22) 0.98 (0.83 to 1.16)
Depression 2.27 (1.76 to 2.91) 2.03 (1.55 to 2.63) 2.15 (1.59 to 2.89)
Sleep duration
 6–9 hours/night 1 (ref) 1 (ref)
 <6 hours/night 2.11 (1.77 to 2.50) 2.11 (1.73 to 2.55)
 ≥9 hours/night 0.70 (0.48 to 0.98) 0.54 (0.34 to 0.81)
Alcohol consumption
 Never 1 (ref)
 1–2 drinks a day 0.98 (0.77 to 1.26)
 ≥3 drinks a day 1.25 (0.92 to 1.70)
Education level
 No graduation 1 (ref)
 No HSD 0.76 (0.51 to 1.16)
 ≥HSD 0.93 (0.64 to 1.39)
Baecke’s score 0.99 (0.94 to 1.04)
Living alone 0.87 (0.73 to 1.04)
Diabetes 0.95 (0.63 to 1.39)
Hypertension 0.93 (0.79 to 1.09)
Prevalent CVD 1.63 (1.01 to 2.56)
Use of sleep medication 0.95 (0.65 to 1.32)
Night working 0.90 (0.46 to 1.63)
Proxy for ethnicity, n (%)
 Caucasian 1 (ref)
 African 0.87 (0.68 to 1.11)
 Non-Caucasian, non-African 1.13 (0.75 to 1.65)

Model 1 is adjusted for age and sex, model 2: model 1+depression, model 3: model 2+sleep duration, model 4: model 3+all covariates listed in the table.

CVD, cardiovascular disease; HSD, high school diploma; Ref, reference category.